Medicare Enrolled
Dr. William Martin, MD
Family Medicine · Graham, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. William Martin is a family medicine in Graham, TX, with 20 years in practice. Based on federal Medicare data, Dr. Martin performed 16,074 Medicare services across 6,093 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martin received a total of $4,746 from 38 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in TX$ $4,746 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,074
Medicare services
Top 1% in TX for family medicine
6,093
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~804 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,940 | $18 | $30 |
| Allergy immunotherapy preparation | 2,370 | $11 | $125 |
| Office visit, established patient (30-39 min) | 1,519 | $83 | $250 |
| Blood draw (venipuncture) | 740 | $8 | $20 |
| Complete blood count (CBC) with differential | 697 | $8 | $40 |
| Comprehensive metabolic blood panel | 683 | $10 | $70 |
| Chronic care management, first 20 min/month | 552 | $47 | $122 |
| Lipid panel (cholesterol and triglycerides) | 535 | $13 | $100 |
| Hemoglobin A1c test (diabetes monitoring) | 367 | $10 | $60 |
| Drug injection, under skin or into muscle | 348 | $9 | $55 |
| Electrocardiogram (EKG), 12-lead | 303 | $10 | $75 |
| Chest X-ray, 2 views | 279 | $21 | $95 |
| Infectious disease DNA/RNA test | 278 | $34 | $100 |
| Advance care planning consultation, first 30 min | 270 | $77 | $253 |
| Annual alcohol misuse screening, 5 to 15 minutes | 269 | $18 | $53 |
| Annual depression screening | 261 | $18 | $75 |
| Annual wellness visit, follow-up | 251 | $124 | $275 |
| Injection, methylprednisolone acetate, 40 mg | 240 | $5 | $25 |
| Office visit, established patient (20-29 min) | 231 | $56 | $170 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 201 | $77 | $125 |
| Ceftriaxone antibiotic injection | 182 | $0 | $7 |
| Testing for presence of drug, read by direct observation | 155 | $12 | $100 |
| Remote patient monitoring management, 20 min/month | 153 | $36 | $149 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 142 | $50 | $100 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 140 | $138 | $1,100 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 138 | $34 | $100 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 138 | $34 | $100 |
| Bone density scan (DEXA) | 125 | $36 | $335 |
| Allergy injection therapy, multiple injections | 116 | $8 | $45 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 115 | $16 | $45 |
| Urinalysis with microscopic exam | 105 | $3 | $35 |
| Dexamethasone injection (steroid) | 94 | $0 | $5 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 89 | $74 | $351 |
| Ultrasound study of arm and leg arteries | 88 | $48 | $246 |
| Ultrasound of heart, follow-up | 86 | $47 | $800 |
| Test to measure expiratory airflow and volume | 84 | $20 | $103 |
| Chronic care management, additional 20 min/month | 76 | $35 | $94 |
| Echocardiogram, transthoracic | 75 | $136 | $608 |
| Remote patient monitoring device, 30 days | 70 | $37 | $177 |
| Steroid injection (triamcinolone) | 63 | $1 | $10 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 48 | $29 | $122 |
| Betamethasone steroid injection | 48 | $4 | $25 |
| Urine microalbumin (protein) analysis | 32 | $6 | $45 |
| Ultrasound of one side of head and neck blood flow | 29 | $86 | $373 |
| Creatinine test (kidney function) | 28 | $5 | $60 |
| Basic metabolic blood panel | 24 | $8 | $60 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 24 | $4 | $40 |
| Destruction of precancerous skin growth, 1 | 23 | $48 | $192 |
| Transitional care management services for problem of high complexity | 22 | $208 | $520 |
| Liver function blood test panel | 21 | $8 | $85 |
| Natriuretic peptide (heart and blood vessel protein) level | 20 | $38 | $200 |
| X-ray of lower and sacral spine, 2-3 views | 19 | $27 | $110 |
| Urinalysis, manual | 19 | $3 | $20 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 18 | $16 | $55 |
| Shoulder X-ray, 2+ views | 16 | $21 | $96 |
| X-ray of abdomen, 2 views | 16 | $25 | $104 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $324 | $1,382 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 16 | $47 | $350 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $127 | $580 |
| Hip X-ray, 2-3 views | 14 | $26 | $131 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 13 | $158 | $489 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 13 | $6 | $50 |
| Transitional care management services for problem of at least moderate complexity | 11 | $156 | $543 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
26.5% medium
72.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,746
Total received (2018-2024)
Avg $678/year across 7 years
Top 14% in TX for family medicine
38
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,746 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$945
2023$751
2022$418
2021$130
2020$230
2019$907
2018$1,364
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$541
AstraZeneca Pharmaceuticals LP
$481
Novo Nordisk Inc
$451
Novartis Pharmaceuticals Corporation
$358
GlaxoSmithKline, LLC.
$346
PFIZER INC.
$316
Amgen Inc.
$312
Astellas Pharma US Inc
$227
Allergan Inc.
$211
ABBVIE INC.
$206
Janssen Pharmaceuticals, Inc
$203
Sunovion Pharmaceuticals Inc.
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Takeda Pharmaceuticals U.S.A., Inc.
$98
Exact Sciences Corporation
$71
Bayer Healthcare Pharmaceuticals Inc.
$66
SANOFI-AVENTIS U.S. LLC
$61
Biohaven Pharmaceutical Holding Company Ltd.
$51
Xeris Pharmaceuticals, Inc.
$44
Merck Sharp & Dohme Corporation
$36
Bayer HealthCare Pharmaceuticals Inc.
$34
Allergan, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$31
Amarin Pharma Inc.
$22
Genentech USA, Inc.
$21
Corium, LLC
$20
Hydrofera LLC
$19
BOSTON SCIENTIFIC CORPORATION
$19
Ethicon US, LLC
$18
Avanir Pharmaceuticals, Inc.
$17
Paratek Pharmaceuticals, Inc.
$17
Mylan Specialty L.P.
$15
Lundbeck LLC
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Supernus Pharmaceuticals, Inc.
$14
Abbott Laboratories
$14
Flexion Therapeutics, Inc.
$11
Daiichi Sankyo Inc.
$11
Top 3 companies account for 31.0% of total payments
Associated products mentioned in payments ›
ANORO · ANORO ELLIPTA · AREXVY · AZSTARYS · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BROVANA · BYSTOLIC · CHANTIX · COMIRNATY · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVUSHELD · FARXIGA · FREESTYLE LIBRE · GVOKE PFS · HYDROFERA BLUE · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINX Reflux Management System · LINZESS · LONHALA MAGNAIR · LYRICA · MOUNJARO · Movantik · Myrbetriq · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QELBREE · QULIPTA · RECORLEV · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · Utibron · VIBERZI · VRAYLAR · VYEPTI · Vascepa · Veozah · Vesicare · Victoza · WATCHMAN · XARELTO · XIFAXAN · Xofluza · Yupelri · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $30 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
17
Per 100K population
94.6
County median income
$63,723
Nearest hospital
GRAHAM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Martin is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Martin performed 2,940 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $4,746 from 38 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other family medicines in Graham?
Dr. Martin's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Graham
Browse family medicines in Graham ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology